Assertio Holdings, Inc. (ASRT)
Largest Insider Buys in Sector
ASRT Stock Price History Chart
ASRT Stock Performance
About Assertio Holdings, Inc.
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, …
Insider Activity of Assertio Holdings, Inc.
Over the last 12 months, insiders at Assertio Holdings, Inc. have bought $105,300 and sold $11,463 worth of Assertio Holdings, Inc. stock.
On average, over the past 5 years, insiders at Assertio Holdings, Inc. have bought $104,412 and sold $2.7M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Mason Heather L (Interim Executive Officer) — $168,500. O'Grady Brendan P. (CEO) — $19,901. Vacirca Jeff L (director) — $11,100.
The last purchase of 75,000 shares for transaction amount of $60,000 was made by Mason Heather L (director) on 2024‑11‑18.
List of Insider Buy and Sell Transactions, Assertio Holdings, Inc.
| 2024-11-18 | director | 75,000 0.0747% | $0.80 | $60,000 | +20.30% | |||
| 2024-11-14 | CEO | 11,706.46 0.0124% | $0.85 | $9,950 | -4.54% | |||
| 2024-06-11 | director | 10,000 0.0108% | $1.11 | $11,100 | +7.87% | |||
| 2024-06-05 | Interim Executive Officer | 25,000 0.0255% | $0.97 | $24,250 | +16.03% | |||
| 2024-03-14 | Sale | director | 10,251 0.0106% | $1.12 | $11,463 | -3.64% | ||
| 2023-09-12 | Sale | President & CEO | 31,121 0.0334% | $2.97 | $92,432 | -63.97% | ||
| 2023-09-11 | Sale | President & CEO | 127,281 0.1363% | $3.04 | $386,972 | -64.92% | ||
| 2023-09-11 | Sale | SVP and CAO | 64,313 0.0689% | $3.04 | $195,795 | -64.92% | ||
| 2023-09-11 | Sale | SVP, General Counsel | 45,236 0.0484% | $3.04 | $137,441 | -64.92% | ||
| 2023-09-11 | Sale | SVP and CFO | 104,980 0.1136% | $3.07 | $322,593 | -64.92% | ||
| 2023-08-14 | Sale | director | 22,000 0.0385% | $3.14 | $69,045 | -66.23% | ||
| 2023-05-19 | Sale | director | 89,286 0.1751% | $7.30 | $652,011 | -83.70% | ||
| 2023-05-05 | Sale | director | 43,143 0.0825% | $6.00 | $258,767 | -65.37% | ||
| 2022-05-12 | Sale | 22,322 0.0431% | $2.35 | $52,488 | +31.56% | |||
| 2022-05-12 | Sale | 44,643 0.0864% | $2.36 | $105,170 | +31.56% | |||
| 2022-04-11 | Sale | President and CEO | 26,391 0.0628% | $3.50 | $92,369 | -2.52% | ||
| 2022-04-05 | Sale | President and CEO | 34,518 0.0829% | $3.50 | $120,813 | -1.59% | ||
| 2021-05-20 | President and CEO | 31,818 0.0736% | $1.54 | $49,000 | +9.40% | |||
| 2021-05-20 | SVP and CFO | 19,500 0.0443% | $1.51 | $29,523 | +9.40% | |||
| 2021-05-20 | SVP and CAO | 16,339.87 0.0375% | $1.53 | $25,000 | +9.40% |
Insider Historical Profitability
| Mason Heather L | director | 287650 0.3013% | $0.95 | 2 | 1 | |
| Vacirca Jeff L | director | 151159 0.1583% | $0.95 | 1 | 0 | |
| O'Grady Brendan P. | CEO | 11706 0.0123% | $0.95 | 1 | 0 | |
| Peisert Daniel A. | President & CEO | 324939 0.3403% | $0.95 | 1 | 4 | +9.4% |
| Patel Ajay | SVP and CAO | 93643 0.0981% | $0.95 | 1 | 1 | +9.4% |
Institutional Investor Ownership
| Nantahala Capital Management Llc | $8.89M | 9.75 | 9.27M | +21.67% | +$1.58M | 0.41 | |
| BlackRock | $6.09M | 6.68 | 6.35M | -3.4% | -$214,335.40 | <0.0001 | |
| The Vanguard Group | $4.72M | 5.17 | 4.92M | +0.84% | +$39,399.41 | <0.0001 | |
| AQR Capital | $3.1M | 3.4 | 3.23M | +61.74% | +$1.18M | 0.01 | |
| Russell Investments Group Ltd | $2.25M | 2.47 | 2.35M | +22,096.18% | +$2.24M | <0.01 |